A new Covid variant Nimbus aka ‘razor blade throat' is on the rise. All you need to know
Where has the Nimbus spread?
The NB.1.8.1 variant has spread rapidly across China and Hong Kong, and cases have now been detected in several US states, including California, Washington, Virginia, and New York, according to an Associated Press report. Australia has also recorded cases. In the UK, 13 cases were confirmed in June, accompanied by a nearly 10 per cent rise in hospitalisations, The Independent reported. The variant and symptoms have also been detected in India.
By mid-May, NB.1.8.1 accounted for nearly 11 per cent of all sequenced COVID samples globally, signaling a rapid rise in circulation.
What are the symptoms?
The most reported and defining symptom of the Nimbus variant is a severely painful sore throat. Other symptoms include fever, chills, cough, shortness of breath, and loss of taste or smell. However, the World Health Organization (WHO) has stated that the variant does not appear to cause more severe illness than previous strains and is currently considered low risk.
What has WHO said?
The WHO has classified NB.1.8.1 as a 'variant under monitoring,' indicating that while it is spreading, it doesn't yet pose a major threat. The organisation has also confirmed that current COVID-19 vaccines remain effective in preventing severe outcomes linked to the variant.
'The WHO assesses the additional risk to the global public as currently low, and existing COVID-19 vaccines are considered effective in preventing severe disease,' Dr Naveed Asif, a general practitioner at The London General Practice, told The Independent.
Which vaccines offer protection?
Vaccines approved by the US FDA – Moderna, Pfizer-BioNTech, and Novavax – are expected to be effective against NB.1.8.1, especially because it belongs to the Omicron JN.1 lineage. An article by New York-Presbyterian/Columbia University Irving Medical Center stresses the importance of staying up-to-date with boosters.
Those with underlying health conditions like diabetes, heart disease, or hypertension should take extra precautions, as their immune response may not be as robust.
Why Nimbus spreads faster
Scientists believe NB.1.8.1 may spread more efficiently due to stronger binding with human cells. A Gavi report noted that the variant binds tightly to the ACE2 receptor, which SARS-CoV-2 uses to enter the body.
'Using lab-based models, researchers found NB.1.8.1 had the strongest binding affinity to the human ACE2 receptor of several variants tested,' said virologist Lara Herrero from Griffith University in The Conversation, 'suggesting it may infect cells more efficiently than earlier strains.'
Dr Chun Tang, a general practitioner at UK-based Pall Mall Medical, added that while the variant isn't drastically different from Omicron, 'some tweaks to its spike protein' may make it more transmissible or help it evade immunity.
'What sets NB.1.8.1 apart is how quickly it spreads,' said Dr Magdalena Sobieszczyk, Chief of Infectious Diseases at New York-Presbyterian/Columbia. 'It has a genetic advantage: mutations that make it easy for it to bind to receptors on human cells.'
Prevention is key
Precautions remain largely the same. Mask up in crowded places, cover your mouth while coughing or sneezing, wash and sanitise your hands regularly, and avoid stepping out if unwell. Ventilated spaces remain safer, especially during spikes in transmission.
No, 'Nimbus' isn't a Harry Potter reference
While some may associate 'Nimbus' with the magical broomstick from 'Harry Potter' or characters from 'Rick and Morty', the nickname actually refers to a type of cloud. Professor T Ryan Gregory of the University of Guelph in Canada explained to Gavi' that naming conventions like 'Nimbus' (NB.1.8.1) and 'Stratus' (XFG) help make emerging variants easier to track and communicate to the public.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
India Today
an hour ago
- India Today
NIT Rourkela study cracks protein puzzle for stronger bone repair
Researchers at the National Institute of Technology (NIT) Rourkela have found how certain natural sugar-like molecules in human body can change the way a key bone protein behaves. The work, published in the journal Biochemistry, offers clues for improving bone and cartilage repair treatments, designing better medical implants, and developing more effective protein-based are workhorses in the human body, building tissues, carrying signals, and supporting chemical reactions. For these roles, proteins must fold into specific three-dimensional in their structure can affect how well they work. Understanding how and why a protein unfolds is a long-standing challenge in biology, with applications ranging from drug delivery to tissue ROURKELA MAPS SUGAR-PROTEIN LINK FOR BETTER BONE REPAIR METHODS The study focused on Bone Morphogenetic Protein-2 (BMP-2), a molecule central to bone and cartilage formation. BMP-2 also helps stem cells turn into bone-forming cells and supports healing after the body, BMP-2 operates in an environment rich in glycosaminoglycans (GAGs), sugar-like molecules found in connective tissue and joint fluids. The NIT Rourkela team, led by Professor Harekrushna Sahoo from the Department of Chemistry, examined how different GAGs affect BMP-2 under chemical scholars Devi Prasanna Behera and Suchismita Subadini worked alongside him in the study. The team used urea to induce unfolding and compared the behaviour of BMP-2 with and without results showed that in the presence of Sulfated Hyaluronic Acid (SHA), a type of GAG, BMP-2 unfolded faster than it did with regular hyaluronic acid or without any study suggests that SHA binds directly to BMP-2, altering its structure in a way that makes the unfolding process more Sahoo explained that BMP-2 functions within a GAG-rich environment in bone tissue, and these molecular interactions shape its structure and understanding these interactions, it may be possible to design scaffolds that keep BMP-2 in its active form for longer, reduce the dosage needed in treatments, and limit side research also points to a broader idea, modifying the functional groups of GAGs, such as through targeted sulfation, could help stabilise proteins like BMP-2 under stress without losing their could guide the creation of new drug formulations, extend protein shelf life, and make therapeutic delivery more mapping these detailed molecular relationships, the NIT Rourkela study provides a framework for future work in regenerative medicine, where fine-tuning the environment around proteins can be as important as the proteins themselves.- Ends
&w=3840&q=100)
First Post
2 hours ago
- First Post
What is myasthenia gravis? Former tennis star Monica Seles opens up about her autoimmune diagnosis
Former world no.1 Monica Seles has come out to raise awareness about myasthenia gravis, a rare neuromuscular autoimmune disease, she got diagnosed with in 2022. Former world no.1 and nine-time Grand Slam champion Monica Seles has revealed her ongoing battle with myasthenia gravis, a rare neuromuscular autoimmune disease, she got diagnosed with in 2022. The 51-year-old has decided to raise awareness about the disease and is speaking openly about it in the lead-up to the US Open 2025, which is scheduled to start on August 24. What is myasthenia gravis? Myasthenia gravis, or MG, is a chronic autoimmune disorder that disrupts nerve-muscle connections. It causes weakness and fatigue in voluntary muscles. It has varied symptoms like double vision, drooping eyelids, slurred speech, and the one suffering from it can face difficulty swallowing. Moreover, there will be muscle weakness in the arms, legs or neck. The immune system could not detect the original threat and mistakenly attacks nerve receptors. As of now, there is no cure for the disease, but there are treatment options like medication and therapy that can manage symptoms and improve quality of life. Also Read | STORY CONTINUES BELOW THIS AD Monica Seles on her battle with myasthenia gravis Discussing the same, Monica Seles revealed when she first noticed the symptoms of MG. She divulged that it happened when she was swinging a racket the way she'd done so many times during, and after, an illustrious career. 'I would be playing with some kids or family members, and I would miss a ball. I was like, 'Yeah, I see two balls.' These are obviously symptoms that you can't ignore,' Seles said. 'And, for me, this is when this journey started. And it took me quite some time to really absorb it, speak openly about it, because it's a difficult one. It affects my day-to-day life quite a lot.' She told the Associated Press. The 51-year-old Seles, who won her first major trophy at age 16 at the 1990 French Open and played her last match in 2003, said she was diagnosed with myasthenia gravis three years ago and is speaking publicly about it for the first time ahead of the U.S. Open, which starts on Aug. 24, to raise awareness about what is known as MG. The National Institute of Neurological Disorders and Stroke calls it 'a chronic neuromuscular disease that causes weakness in the voluntary muscles' and 'most commonly impacts young adult women (under 40) and older men (over 60) but … can occur at any age, including childhood.' Seles said she'd never heard of the condition until seeing a doctor and being referred to a neurologist after noticing symptoms such as double vision and weakness in her arms — 'just blowing my hair out … became very difficult,' she said — and legs. 'When I got diagnosed, I was like, 'What?!'' said Seles, who is partnering with argenx, an immunology company headquartered in the Netherlands, to promote their Go for Greater campaign. 'So this is where — I can't emphasize enough — I wish I had somebody like me speak up about it.' STORY CONTINUES BELOW THIS AD It's been three decades since Seles returned to competition at the 1995 U.S. Open, making it to the final, more than two years after she was attacked by a man with a knife at a tournament in Hamburg, Germany. 'The way they welcomed me … after my stabbing, I will never forget,' Seles said about the fans in New York. 'Those are the moments that stay with you.' She talks about learning to live a 'new normal' nowadays and characterized her health as another in a series of life steps that required adapting. 'I had to, in tennis terms, I guess, reset — hard reset — a few times. I call my first hard reset when I came to the U.S. as a young 13-year-old (from Yugoslavia). Didn't speak the language; left my family. It's a very tough time. Then, obviously, becoming a great player, it's a reset, too, because the fame, money, the attention, changes (everything), and it's hard as a 16-year-old to deal with all that. Then obviously my stabbing — I had to do a huge reset," Seles said. STORY CONTINUES BELOW THIS AD 'And then, really, being diagnosed with myasthenia gravis: another reset. But one thing, as I tell kids that I mentor: 'You've got to always adjust. That ball is bouncing, and you've just got to adjust,'' she added. 'And that's what I'm doing now.' (With inputs from AP)
India Today
2 hours ago
- India Today
Indian-origin US doctor fined $2M for false surgery billing fraud
A 63-year-old Indian-origin pain medicine doctor based in Houston, Texas, has agreed to pay more than $2 million (approximately Rs 17.4 crore) to settle allegations of healthcare fraud, according to the US Ajay Aggarwal agreed to pay $2,053,515 to resolve claims that he submitted false billing to Medicare and to the Department of Labor's Workers' Compensation Programs between November 2021 and March 2023, for surgical procedures that were never actually is an anesthesiologist and pain medicine doctor who also practices in Texas' Bellaire city, Lake Jackson city and Van Vleck (in Matagorda County). He runs his medical practice, called The Pain Relief & Wellness Center, through his own business and a company named PRWCSWTX LLC, according to the statement issued on Monday (August 11) by the US Attorney's Office, Southern District of Texas. Aggarwal billed federally funded healthcare programmes for the surgical implantation of neurostimulator electrodes, according to the statement. These are invasive procedures usually requiring use of an operating room. As a result, Medicare and other federally funded healthcare programmes pay thousands of dollars per procedure, the statement neither Aggarwal nor his staff performed these surgical procedures, according to the allegations, the statement further investigators said Aggarwal instead used electro-acupuncture devices on his patients, which involved inserting thin wires into the ear and taping a small neurostimulator behind the ear – none of which required surgery or treatments were done at Aggarwal's clinic, not a hospital or surgical centre, and no incision was made on a patient, according to the VOWS TO RECOVER LOSSES FROM FRAUDULENT MEDICARE BILLINGUS attorney Nicholas J Ganjei slammed the "fraudulent billing" by the doctor and vowed to recover the losses."A doctor who uses simple medical devices on his patients, yet bills Medicare for a sophisticated spinal surgery, is bilking the American taxpayer, plain and simple," said Ganjei."The Southern District of Texas will ensure that losses to federally funded healthcare programs from fraudulent billing, like what happened here, are recouped and that wrongdoers are held accountable," the attorney month, a doctor of Indian-origin admitted guilt to federal charges related to illegally prescribing strong opioids, resulting in the overdose deaths of two part of his plea, Sanjay Mehta admitted to writing unjustified prescriptions for oxycodone, methadone, and Roxicodone (a branded form of oxycodone hydrochloride) to three different patients in Virginia."Two of the three customers died of opioid intoxication within days of receiving their unlawful prescriptions," US Attorney's Office said in a quantum of Mehta's punishment will be announced on October 31.- Ends
